Wills Eye at ARVO

The Association for Research in Vision and Ophthalmology (ARVO) is the leading international research organization for the vision research community.  The annual meeting is the largest meeting of basic and clinical researchers from around the world who come to together to share novel and cutting-edge breakthroughs in eye and vision research. Wills Eye faculty, staff and trainees actively participate at ARVO each year, contributing to new knowledge and ideas to advance prevention and treatment of eye diseases and patient care.

This year, at the 2019 ARVO Annual Meeting in Vancover, British Columbia, Wills Eye faculty, staff, fellows, residents and medical students will give 29 presentations and are co-authors/collaborators on an additional 19 presentations.

SESSIONSTIME AND LOCATIONPRESENTERSTOPIC
PAPER SESSIONS
Sunday April 28, 2019
RE: Emerging AMD Therapeutics3:15 – 3:30 PM
Room 55
Presentation # 971
Freeman W, Bandello F, Souied E, Guymer R, Garg S , Chen F, Rich R, Holz F, Li Y, Kerr K, Lopez FPhase 2b Study of Brimonidine DDS: Potential Novel Treatment for Geographic Atrophy
Tuesday April 30, 2019
GL: Visual Fields, Psychophysics, and Electrophysiology8:45 – 9:00 AM
Room 210
Presentation # 2855
Wang M, Shen L, Pasquale L, Boland M, Wellik S, Moraes C, Myers J , Bex P, Saeedi O, Baniasadi N, Wang H, Li D, Tichelaar J, Elze TCentral Visual Field Loss Patterns in Glaucoma
AP: Non-Melanoma Tumors: Genetics and Therapeutics9:15 – 9:30 AM
Room 198
Presentation # 2778
Lim L, Dalvin L, Lezama D, Chang M, Mashayekhi A, Shields CIntravitreal melphalan for vitreoretinal lymphoma
GL: Visual Fields, Psychophysics, and Electrophysiology9:30 – 9:45 AM
Room 210
Presentation # 2858
Tichelaar J, Wang M, Shen L, Pasquale L, Boland M, Wellik S, Moraes C, Myers J , Bex P, Saeedi O, Baniasadi N, Li D, Wang H, Elize TDefect Classes of Visual Field Measurement in Glaucoma
GL: Laser Therapy10:15 – 10:30 AM
Room 205
Presentation # 2829
Bonafede L, Tran J, Hark L, Sanvicente C, Zhang Q, Costello R, Katz LBeliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma
RE: Update on Endophthalmitis12:30 – 12:45 PM
Room 229
Presentation # 3255
Lee C, Kasi S , Hong B, Ali F, Akleswaran L, Garg S , Gelder RGenomic and gene expression analyses of pathogens in post-surgical endophthalmitis
EY: Mechanisms and biomechanics of traumatic retinal hemorrhage in children3:20 – 3:35 PM
Room 265
Presentation # 3903
Levin, ARetinal hemorrhage: Science versus speculation
Wednesday May 1, 2019
EY: Optic Neuropathy10:30 – 10:45 AM
Room 322
Presentation # 4806
Yu-Wai-Man P, Moster M , Sadun A, Klopstock T, Clermont C, Newman N, Sergott R , Carelli V, Chevalier C, Blouin L, Taiel M, Katz B Sahel JrAAV2/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): 72-Week Data from the REVERSE Phase III Clinical Trial
POSTER SESSIONS
Sunday April 28, 2019
CL: AMD screening, risk factors and consequences8:00 – 9:45 AM
West Exhibition Hall 10
Poster # A0143
Sivalingam M, Gervasio K, Wu C, Matsunaga D, Uhr J, Obeid A, Wibbelsman T, Levine H, Pandit R, Jenkins T, Xu D, Hsu J, Ho ASociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients
RE: AMD anti-VEGF I8:00 – 9:45 AM
West Exhibition Hall 11
Poster # A0260
Hsu J, Obeid A, Mellen P, Wibbelsman T, Konkoly M, Velez M, Calem D, Sioufi K, Su D, Storey P, Klufas M, Spirn M, Regillo C, Ho AShort-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab
RE: AMD anti-VEGF II8:00 – 9:45 AM
West Exhibition Hall 12
Poster # A0317
Li V, Gabriel I, Li M, Antoszyk A, Baker C, Dugel P, Goldberg R, Heier J, Ho A , Pollack J, Wykoff C, Vavvas D, Li WTreatment and Management of Neovascular AMD: Impact on Patients
GL: Laser Therapy1:00 – 2:45 PM
West Exhibition Hall 45
Poster # B0165
Wu C, Kuley B, Zheng C, Lin M, Moster S, Schmidt C, Moster M, Pro M, Lee DOutcomes of selective laser trabeculoplasty after prior incisional surgery for open-angle glaucoma
GL: Laser Therapy1:00 – 2:45 PM
West Exhibition Hall 45
Poster # B0167
Copparam S, Kuley B, Zheng C, Lin M, Moster S, Schmidt C, Moster M, Lee D, Pro M Outcomes of repeat selective laser trabeculoplasty for open-angle glaucoma
IM: Clinical and epidemiological aspects of infection1:00 – 2:45 PM
West Exhibition Hall 49
Poster # B0341
Dohse N , Wibbelsman T, Rapuano S, Hammersmith K, Nagra P, Rapuano C, Syed ZMicrobial Keratitis After Penetrating and Endothelial Keratoplasty
AP: Clinical Melanoma. Therapy and Complications1:00 – 2:45 PM
West Exhibition Hall 46
Poster # B0199
Chang M, Dalvin L, Lim L, Mazloumi M, Yaghy A, Mashayekhi A, Shields CProphylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age
AP: Clinical Melanoma. Therapy and Complications1:00 – 2:45 PM
West Exhibition Hall 46
Poster # B0203
Yanghy A, Dalvin L, Yu M, Mazloumi M, Shields CPhotoreceptor Morphology and Correlation with Subretinal Fluid Chronicity Associated with Choroidal Nevus
LE: Cataract Surgery I1:00 – 2:45 PM
West Exhibition Hall 38
Poster # A0487
Moustafa G, Borkar D , Eton E, Koulisis N, Kloek CPredictors of Non-adherence to Follow-up after Cataract Surgery: Results from the PCIOL Study
AP: Clinical Melanoma. Therapy and Complications1:00 – 2:45 PM
West Exhibition Hall 38
Poster # A0487
McCannel T, Bhavsar A, Capone A, Demirici H, Kim I, Marr B, Rich C, Schefler A, Shields CTwo-year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma
CL: Diabetic eye disease3:00 – 4:45 PM
West Exhibition Hall 68
Poster # A0028
Nezhad G, Vardanjani H, Razeghinejad M , Janghorbani M Discrepancies in the epidemiology of diabetic retinopathy among diabetes clinics, eye clinic, and population-based studies: A Systematic Review, and Meta-Analysis
RE: AMD clinical research II3:00 – 4:35 PM
West Exhibition Hall 71
Poster # A0211
Soares R, Mellen P, Garrigan H, Obeid A, Wibbelsman T, Borkar D, Ho A, Hsu JOutcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF
Monday April 29, 2019
RE: Endophthalmitis: clinical11:15 AM – 1:00 PM
West Exhibition Hall 136
Poster # B0041
Patel S, Storey P, Pancholy M, Obeid A, Wibbelsman T, Levin H, Hsu J, Garg S, Dunn J, Vander J The utility of vitreous cultures in the management of endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents
RE: Endophthalmitis: clinical11:15 AM – 1:00 PM
West Exhibition Hall 136
Poster # B0052
Levin H, Storey P, Pancholy M, Patel S, Wibbelsman T, Obeid A, Ho AEndophthalmitis following cataract surgery: visual outcomes and culture results
CL: Glaucoma risk factors, progression, and management11:15 AM – 1:00 PM
West Exhibition Hall
134
Poster # A0531
Jiang A, Jordan C, Murphy J , Sanvicente C , Fudemberg SCost sharing of glaucoma medications: are patients able to predict the amount of their financial obligation?
LV: Visual Impairment - Measures of Visual Function11:15 AM – 1:15 PM
West Exhibition Hall 129
Poster # A0101
Cideciyan A, Jacobson S, Drack A, Ho A , Garafalo A, Roman A, Schwartz M, Biasutto P, Wit W, Cheetham M, Adamson P, Rodman D, Zaeytijd J, Cauwenbergh C, Leroy B, Russell SCEP290-associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision
RE: Diabetic Macular Edema Clinical Research4:00 – 5:45 PM
West Exhibition Hall 179
Poster # B0176
Kuley B , Storey P, Pancholy M, Obeid A, Murphy J , Goodman J , Wibbelsman T, Regillo C, Chiang AOcular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone
AP: Retinoblastoma4:00 – 5:45 PM
West Exhibition Hall 170
Poster # A0380
Camp D, Dalvin L, Schwendeman R, Lim L, Shields CNeonatal Retinoblastoma: Analysis of Treatment Outcomes in the Pre-Chemotherapy, Intravenous Chemotherapy, and Intra-arterial Chemotherapy Eras
GL: Clinical Studies4:00 – 5:45 PM
West Exhibition Hall 172
Poster # A0557
Ustaoglu M, Shiuey E , Sanvicente C, Razeghinejad R, Katz L, Myers J, Lee DThe Efficacy and Safety Profile of Netarsudil 0.02% in Glaucoma Treatment: Real-World Outcomes
GL: Visual Fields, Psychophysics, and Electrphysiology4:00 – 5:45 PM
West Exhibition Hall 174
Poster # A0624
Li D, Shen L, Pasquale L, Boland M, Wellik S, Moraes D, Myers J , Bex P, Saeedi O, Baniasadi N, Wang H, Tichelaar J, Elze T, Wang MBaseline Visual Field (VF) Patterns are Predictive of Global and Central Loss in 24-2 Visual Fields
GL: IOP Measurement4:00 – 5:45 PM
West Exhibition Hall 173
Poster # A0593
Price J, Levin AWhen is iCare High Care?
CL: Ocular Trauma4:00 – 5:45 PM
West Exhibition Hall 176
Poster # B0009
Ramsay C, Murchison A, Bilyk JPrevalence of pediatric eye trauma and ER usage rates: pediatric ophthalmic trauma presenting to a an ophthalmic-only ER from 2012-2013.
Tuesday April 30, 2019
AP: Non-Melanoma, Non-Retinoblastoma Intraocular Pathology & Retinopathy11:45 AM – 1:30 PM
West Exhibition Hall 244
Poster # A0591
Acaba-Berrocal L , Williams B, Di-Nicola M, Alvarez J, Shields J, Shields CAdenoma and adenocarcinoma of the retinal pigment epithelium: clinical and imaging characteristics, treatment options and histopathologic findings in 51 consecutive patients
IM: Uveitis and scleritis - clinical therapeutics and checkpoint inhibitors11:45 AM – 1:30 PM
West Exhibition Hall 243
Poster # A0551
Mckay K, Borkar D , Sevgi D, Papaliodis G, Sobrin LModified Anterior Sub-Tenon’s Periocular Steroid Injection for Treatment of Intraocular Inflammation and Cystoid Macular Edema
CL: Consequences of vision impairment11:45 AM – 1:30 PM
West Exhibition Hall 248
Poster # B0060
Wizov S , Shiuey E, Sanvicente C , Leiby B, Tran J, Waisbourd M, Myers J, Katz L , Moster M, Spaeth GRisk of auto accidents in patients with moderate-stage glaucoma
GL: Surgery and Wound Healing I11:45 AM – 1:30 PM
West Exhibition Hall 252
Poster # B0282
Myers J, Zheng C, Moster S, Lin MShort term outcomes of transconjunctival ab externo XEN 45 Gel Stent implantation
AP: Non-Melanoma, Non-Retinoblastoma Intraocular Pathology & Retinopathy11:45 AM – 1:30 PM
West Exhibition Hall 244
Poster # A0584
Dalvin L, Lim L, Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CSurvival Times in Patients with Vitreoretinal Lymphoma. Analysis of 95 Patients at a Single Ocular Oncology Center
CL: Retinal disease epidemiology2:45 – 4:30 PM
West Exhibition Hall 270
Poster # A0460
Pandit R , Wibbelsman T , Jenkins T , Xu D , Obeid A , Ho AFactors predicting distribution and practice patterns of retina providers across the United States (US)
CL: Retinal disease epidemiology2:45 – 4:30 PM
West Exhibition Hall 270
Poster # A0472
Levin A, Guimarães T, Ibañez M, Capasso JStargardt Misdiagnosis: How Ocular Genetics Helps
CL: Retinal disease epidemiology2:45 – 4:30 PM
West Exhibition Hall 270
Poster # A0466
Uhr J, Obeid A, Wibbelsman T, Wu C, Hsu JIncidence and Timing of Delayed Retinal Breaks Following Acute Symptomatic Posterior Vitreous Detachment
RE: Retinal Vascular Diseases I2:45 – 4:30 PM
West Exhibition Hall 274
Poster # B0113
Wibbelsman T, Calem D , Obeid A, Mellen P, Konkoly M, Velez M , Sioufi K, Borkar D, Pandit R, Klufus M, Hsu J, Regillo C, Ho A, Gupta O, Spirn MClinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion
RE: Retinal Vascular Diseases I2:45 – 4:30 PM
West Exhibition Hall 274
Poster # B0110
Khoo C, Udyaver S, Dalvin L, Lim L, Atalay H, Mazloumi M, Shields C Factors predictive of retinal detachment resolution in Coats disease: Analysis of 187 eyes in 184 patients at a single center
Wednesday May 1, 2019
CL: Prevalence of vision impairment8:15 – 10:00 AM
West Exhibition Hall 302
Poster A0341
Wey S, Ramsay C, Li L, Lee D Effectiveness of an educational intervention on glaucoma for a Mandarin-speaking population in Philadelphia: A proof of concept study
EY: Amblyopia- Vision Screening and Epidemiology8:15 – 10:00 AM
West Exhibition Hall 300
Poster # A0309
Vagge A, La Mattina K, Nelson LAccuracy of the Red Reflex Test to Detect Unequal Refractive Error
RE: Macular Diseases Excluding AMD10:15 AM – 12:00 PM
West Exhibition Hall 333
Poster # A0510
Xu D, Obeid A, Levin H, Matsunaga D, Gervasio K, Jenkins T, Pandit R, Ho AEtiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50
GL: Trabecular Meshwork and Ciliary Body10:15 AM – 12:00 PM
West Exhibition Hall 336
Poster # B0563
Moster S, Zheng C, Lin M, Copparam S, Lee DSurgical outcomes of trabecular micro-bypass (iStent) surgery performed by ophthalmology resident trainees compared to attending surgeons
LV: Visual Impairment and Patient Reported Outcomes10:15 AM – 12:00 PM
West Exhibition Hall 331
Poster # A0373
Harley M, Malik K , Sanvicente C, Spaeth G, Lee DThe Relationship between Patients’ Clinical Behavior, Physician Impressions and Glaucoma Progression
PH: Diabetic retinopathy, cytokines and growth factors3:00 – 4:45 PM
West Exhibition Hall 369
Poster # B0054
Klufas M, Chiang A, Hill L, Tsuboi M, Stoilov I Patients ultra-responsive to ranibizumab: rates of ≥4-step improvement in diabetic retinopathy severity in DRCR.net Protocol S
Thursday May 2, 2019
EY: Orbit and Thyroid eye Disease8:00 – 9:45 AM
West Exhibition Hall 409
Poster # B0197
Gervasio K, Godfrey K, Winebrake J, Lee M, Sippel K, Lai E, Lelli GUtility of PROSE in thyroid eye disease patients with recurrent proptosis after orbital decompression
GL: Surgery and Wound Healing II10:15 AM – 12:00 PM
West Exhibition Hall 432
Poster # B0096
Dugan C, Ustaoglu M, Zheng C, Lin M, Moster S, Sanvicente C, Moster M Outcomes of Ahmed glaucoma valve implantation modified with viscoelastic anterior chamber fill